Physician profile
David G Florence
NPI 1881676856
$944.94
in general payments reported to CMS, 2019-2025
11 companies · $22.01 in 2025
The $22.01 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $455 · 2020: $106 · 2021: $68.95 · 2022: $58.92 · 2023: $109 · 2024: $125 · 2025: $22.01.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $256.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $255.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axsome Therapeutics, INC. | $233.63 | 2023-2024 | Auvelity |
| Novartis Pharmaceuticals Corporation | $192.87 | 2019-2020 | |
| Novo Nordisk INC | $159.57 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $81.02 | 2019 | |
| Abbvie INC. | $68.95 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $51.21 | 2019-2020 | |
| Teva Pharmaceuticals USA, INC. | $49.17 | 2019-2020 | |
| Pfizer INC. | $44.88 | 2019-2020 | |
| Mylan Specialty L.P. | $29.46 | 2019 | |
| Conmed Corporation | $22.01 | 2025 | Airseal, Conmed Specimen Retrieval |
| Zyla Life Sciences, INC. | $12.17 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Florence listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.